A prospective cross sectional analysis of serum lipids was carried out in 20 children aged between 1.3 and 16 years with Kawasaki disease (KD). The controls were siblings of other patients. The mean interval between diagnosis of the disease and time of assay was 2.6 years (range 0.41 to 6 years). Standard biochemical methods were employed for determination of various components of the lipid profiles. There were significant differences in high-density lipoprotein cholesterol (HDL-C) (40.37 ± 12.0 mg/dL versus 53.49 ± 4.31 mg/dL, P < 0.001) and low-density lipoprotein cholesterol (LDL-C) concentrations (77.76 ± 26.25 mg/dL versus 57.7 ± 23.2 mg/dL, P < 0.05) between the cases and controls. Lower HDL-C levels persisted at 1-3 and more than 3 years of disease duration. No significant differences were seen in the values of other parameters in the lipidogram, such as total cholesterol (TC), triglycerides (TG), and very low-density lipoprotein cholesterol (VLDL-C). Premature atherosclerosis that occurs in KD may be secondary to these lipid metabolism abnormalities. ( 1) This endothelial dysfunction is a precursor of atherosclerosis and subsequent coronary artery damage.
METHODS
The study sample consisted of 20 children diagnosed as having KD based on the criteria of the American Heart Association as follows: 5) • Fever of at least 5 days in duration • Presence of 4 of the following principal features:
1. Changes in extremities 2. Polymorphous exanthem 3. Bilateral conjunctival injection 4. Changes in lips and oral cavity 5. Cervical lymphadenopathy • Exclusion of other diseases with similar findings Children on medications known to influence lipoprotein metabolism such as steroids, thiazides, and propranolol were excluded. Those having other diseases with similar findings and/or liver, renal, biliary or thyroid disease were also excluded based on clinical examination and appropriate laboratory investigations. All children had been followed-up in the Pediatric Rheumatology and Immunology Clinic of the Advanced Pediatric Center for a minimum of 3 months after diagnosis of KD. Controls were normal siblings of patients attending the outpatient clinic or admitted to a ward for other illnesses. The selections of controls were case-control study based. The study was approved by the Institute Ethics Committee.
A fasting sample of 4 mL blood was collected in a plain vial after sterile venupuncture. Two mL of this was sent under the real name of the patient (sample 1) and 2 mL was labeled with a random number (sample 2), thereby blinding the laboratory personnel dealing with the sample. Blood was allowed to clot at room temperature for 2 hours. The samples were then transferred to the Hypertension Research Laboratory of the Department of Experimental Medicine and Biotechnology. Serum was separated and stored at -20°C until the time of assay. Samples were analyzed in batches to minimize interassay variation. A similar procedure was used to obtain and process control samples. Biochemical methods: Total cholesterol was determined by an enzymatic method (CHOD.PAP) using cholesterol esterase, cholesterol oxidase, and peroxidase with a standard kit. 7) In this method, cholesterol esterase hydrolyses cholesterol esters into free cholesterol, which is oxidized to cholesterol-4-en-3-one and hydrogen peroxide by cholesterol oxidase. Hydrogen peroxide couples with 4-aminoantipyrine and phenol to form a red quinonine dye having maximal absorbance at 510 nm, which is measured spectrophotometrically. Each assay was performed in duplicate to ensure quality control and a reference control serum was incubated with each assay. HDL-C was measured by precipitation of chylomi-Vol 46 No 5 crons, and VLDL-C and LDL-C by the addition of phosphotungstic acid and magnesium chloride. After centrifugation the supernatant fluid containing the HDL fraction was assayed for HDL-C with a standard liquicolor test kit. The LDL-C concentration was calculated from the total cholesterol concentration, the HDL cholesterol concentration, and the triglyceride concentration according to Friedewald, et al, that is, LDL-C (mg/dL) = TC([HDL -C + (TG/5)]. Triglycerides were determined after enzymatic hydrolysis with lipases by the GPO. PAP method using a standard kit. VLDL-C was calculated by dividing triglycerides by 5 (in fasting plasma, most triglycerides are in VLDL and the ratio of triglycerides to cholesterol in VLDL is approximately 5:1). All lipid assays were carried out using kits provided by Accurex Biomedical Private Limited, India. These kits have previously been standardized and used extensively in the Department of Experimental Medicine & Biotechnology. Statistical methods: Conventional distance statistics were employed for calculating the mean and standard deviation for each of the parameters included in the study. The difference between the 2 values of each variable of study sample was quantified by applying a paired t-test and the difference between study and control samples with respect to each variable was quantified by applying an unpaired t-test.
RESULTS
The basic characteristics of the study population are shown in Table I . The interval between diagnosis of the disease and time of assay in the study group varied from 0.41 years to 6 years, with a mean duration of 2.6 years. Eighteen out of 20 children in our study had an interval of 1-3 years between the diagnosis and time of assay. Eighteen children had received intravenous immunoglobulins during the acute stage; the remaining 2 who did not receive immunoglobulin therapy had been referred to us late in the convalescent phase and had already become afebrile at the time of admission.
There was no significant interassay variablity in different variables of the lipidogram. The mean values of sample 1 (unblinded) and sample 2 (blind labeled) were also comparable (Table II) . There were significant differences in the HDL-C (40.37 ± 12.0 mg/dL versus 53.49 ± 4.31 mg/dL, P < 0.001) and LDL-C (77.76 ± 26.25 mg/dL versus 57.7 ± 23.2 mg/dL, P < 0.05) levels persistently between cases (mean of sample 1 and sample 2) and controls (Table III) . There were no significant differences in the values of other parameters of the lipidogram (TC, TG, and VLDL-C). Also, low HDL-C levels persisted with increasing duration of the disease though other variables did not show similar findings (Table IV) . A total of 17 patients had abnormal lipid profiles. All 17 had abnormal HDL-C levels, 12 had abnormal values for 2 parameters (HDL-C and LDL-C), 7 patients had abnormal values for 3 parameters (HDL-C, LDL-C and TC), and 3 had abnormal values for all 5 parameters studied. 
DISCUSSION
Kawasaki disease predominantly affects medium-sized vessels and is the commonest cause of acquired heart disease in many developed countries. A diagnosis is rarely made in developing countries because of its nonspecific and gradually evolving symptoms, no confirmatory laboratory test, and above all a lack of awareness amongst pediatric practitioners. 5) Consequently, information about factors affecting long-term outcomes is scarce from developing countries, including India. 4, 5) The large cohort of about 70 patients at our hospital is primarily related to a heightened index of suspicion. The present study on a subgroup of our patients is an initial attempt to characterize their lipid abnormalities, considered to be a cause of endothelial dysfunction, 1) that can lead to atherosclerosis and subsequent coronary artery disease.
2,3)
It is interesting to note that the total HDL-C values were significantly lower in the study group as compared to controls even after several years of recovery from KD. This was true for both study samples obtained for this purpose. Similar observations have been made previously. Newburger, et al studied lipid profiles in 105 patients up to 3 years after KD and noted a decrease in HDL-C, which improved during recovery, although lower HDL-C levels persisted. 8) Likewise, Salo, et al observed lower HDL-C levels in the acute phase which returned to normal in the long-term. 9) Thus, the changes in HDL-C levels may be long standing but not permanent. As observed by the above investigators, it is possible that the lower HDL-C values seen in our patients may also return to normal on longer follow-up. The acute changes in HDL-C are considered to be a result of alterations in lipoprotein composition during the acute phase of KD.
10) The suggested mechanism is similar to that observed during viral and bacterial infections and is mediated by cytokines. 11) Since we did this analysis beyond the acute phase, the measurement of pro-or anti-inflammatory parameters was not carried out.
HDL-C has emerged as an important predictor of coronary heart disease. The Tromso study mentions that the high HDL-C levels are protective against coronary heart disease at all levels. 12) In view of this it appears that these abnormalities (lower HDL-C levels) in our children could be of long-term significance. The premature atherosclerosis known to occur as a complication in KD may be the result of these abnormalities in lipid metabolism.
In our study, the levels of LDL-C were also found to be higher in the cases than controls. None of the previously published studies reported such findings. [8] [9] [10] LDL-C is known to be an important and independent risk factor in the development of coronary artery diseases by predisposing to atherosclerosis.
The values of VLDL-C and TG in this study were not statistically different in the cases and controls. All 3 previously mentioned studies reported abnormal-ities in the acute phase that later returned to normal. Since we studied our patients in the convalescent phase, it is not surprising that the TG and VLDL-C levels were found to be normal.
Control values for lipids have however varied considerably in the published literature. Mirza, et al studied lipid profiles in 45 normal healthy children. 13) Mean serum cholesterol was 166.2 mg/dL, TG 57.2 mg/dL, LDL-C 80 mg/dL, VLDL-C 11 mg/dL, and HDL-C 75 mg/dL. The values were similar in boys and girls but these varied with social class and type of fat consumed. In another study on 410 healthy children aged 3-12 years, mean serum cholesterol was 134.5 mg/ dL, TG 91.1 mg/dL, LDL-C 80 mg/dL, and HDL-C 34.15 mg/dL. Again no difference was noted in relation to age and sex.
14) The HDL-C values obtained in our study were significantly lower, even when compared with normal values from other geographical areas.
We performed duplicate analyses in an attempt to minimize any potential biases in the results. The lack of any significant differences in the values of sample 1 and sample 2 indirectly suggests the reproducibility and accuracy of our methods. Similarly, the incubation of reference control serum with each assay was conducted to ensure quality control. Control sera however could not be subjected to duplicate analysis because of cost constraints.
A limitation of the present study is the small number of patients and hence lack of sufficient statistical power to exclude chance as an explanation for differences observed in the values. Although significantly different from the normal population and the control groups, the magnitude of the changes in lipid profile were not extreme and may only represent a minimal increase in cardiovascular risk whose long-term significance is nevertheless unclear.
